Implementations by Phenotype

Title Phenotype Institution Algorithm Type Total Cases Total Controlssort descending PPV Sensitivity
RBC Northwestern Implementation Red Blood Cell Indices Northwestern University Case Only 98% 91%
Columbia Depression Implementation Depression Columbia University Medical Center Case, Control
CKD for NU eMERGEseq subjs Chronic Kidney Disease Northwestern University Case, Control
Mayo CAAD cases and controls CAAD (Carotid Artery Atherosclerosis Disease) Mayo Case, Control 13 100% 71%
VU E3 implementation Clostridium Difficile Colitis Vanderbilt University Medical Center Case, Control
VUMC Post-event Pain Post-event Pain algorithm VUMC Case Only
Sickle Cell Froedtert Hospital Implementation Sickle Cell Disease Froedtert Hospital Case Only 96% 98%
Sleep Apnea-Columbia Sleep Apnea Phenotype Columbia University Case Only
Cardiac Conduction Marshfield Implementation Cardiac Conduction (QRS) Marshfield Clinic Research Foundation Case Only 100%
Group Health DILI algorithm implementation Drug Induced Liver Injury Group Health Research Institute Case, Control
Height Northwestern Implementation Height Northwestern University Case Only 95%
CHOP Post-event Pain Post-event Pain algorithm CHOP Case, Control 99 2 96%
Early Childhood Obesity Implementation - Columbia Severe Early Childhood Obesity Columbia University Case, Control 2 3
Marshfield Zoster implementation Herpes Zoster Marshfield Clinic Research Foundation Case, Control 10 10 100%, 100%
Marshfield C-diff implementation Clostridium Difficile Colitis Marshfield Clinic Research Foundation Case, Control 21 10 100%, 100%
Appendicitis Case 1, Control Appendicitis Cincinnati Children's Hospital Medical Center Case, Control 15 20 93%, 100%
Geisinger c.Diff eMERGE3 Implementation Clostridium Difficile Colitis Geisinger Case, Control 20 20 100%, 100% 100%, 100%
Marshfield AAA implementation Abdominal Aortic Aneurysm ( AAA ) Marshfield Clinic Research Foundation Case, Control 25 22 100%, 100%
Marshfield Hearing loss validation Hearing Loss Marshfield Clinic Research Foundation Case, Control 25 25 100%, 100%
Statin and MACE Mount Sinai Implementation Statins and MACE Mount Sinai Case Only 52 25 96%, 100% 100%, 100%
Group Health and UW Zoster Implementation Herpes Zoster Group Health and UW Case, Control 25 25 100%, 96% 100%
Implementation For Phase 3 eMERGE Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia Geisinger Case, Control 25 25 100%, 96%
Group Health/University of Washington CRC Validation Colorectal Cancer (CRC) GH/UW Case, Control 25 25 92%, 100% 100%, 100%
Marshfield ACE-I cough implentation ACE Inhibitor (ACE-I) induced cough Marshfield Clinic Research Foundation Case, Control 25 25 100%, 96%
Geisinger Impl Colorectal Cancer (CRC) Geisinger Case, Control 25 25 100%, 100%

Pages